Annual Working Capital
$504.20 M
+$435.36 M+632.36%
31 December 2023
Summary:
MoonLake Immunotherapeutics annual working capital is currently $504.20 million, with the most recent change of +$435.36 million (+632.36%) on 31 December 2023. MLTX annual working capital is now at all-time high.MLTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$492.24 M
-$32.36 M-6.17%
30 September 2024
Summary:
MoonLake Immunotherapeutics quarterly working capital is currently $492.24 million, with the most recent change of -$32.36 million (-6.17%) on 30 September 2024. Over the past year, it has increased by +$2.53 million (+0.52%). MLTX quarterly working capital is now -9.63% below its all-time high of $544.68 million, reached on 31 March 2024.MLTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +632.4% | +0.5% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MLTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +4503.2% | -9.6% | +4398.7% |
| 5 y | 5 years | at high | +4503.2% | -9.6% | +4398.7% |
| alltime | all time | at high | +4503.2% | -9.6% | +4398.7% |
MoonLake Immunotherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $492.24 M(-6.2%) |
| June 2024 | - | $524.60 M(-3.7%) |
| Mar 2024 | - | $544.68 M(+8.0%) |
| Dec 2023 | $504.20 M | $504.20 M(+3.0%) |
| Sept 2023 | - | $489.70 M(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $499.23 M(+742.9%) |
| Mar 2023 | - | $59.23 M(-14.0%) |
| Dec 2022 | $68.85 M(-701.2%) | $68.85 M(-16.6%) |
| Sept 2022 | - | $82.52 M(-12.7%) |
| June 2022 | - | $94.52 M(-925.4%) |
| Dec 2021 | -$11.45 M | -$11.45 M |
FAQ
- What is MoonLake Immunotherapeutics annual working capital?
- What is the all time high annual working capital for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual working capital year-on-year change?
- What is MoonLake Immunotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly working capital year-on-year change?
What is MoonLake Immunotherapeutics annual working capital?
The current annual working capital of MLTX is $504.20 M
What is the all time high annual working capital for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual working capital is $504.20 M
What is MoonLake Immunotherapeutics annual working capital year-on-year change?
Over the past year, MLTX annual working capital has changed by +$435.36 M (+632.36%)
What is MoonLake Immunotherapeutics quarterly working capital?
The current quarterly working capital of MLTX is $492.24 M
What is the all time high quarterly working capital for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly working capital is $544.68 M
What is MoonLake Immunotherapeutics quarterly working capital year-on-year change?
Over the past year, MLTX quarterly working capital has changed by +$2.53 M (+0.52%)